Read more at The Wall Street Journal.
Why Pfizer Will Find It Hard to Appease Its Activist Investor
Date: |
Topics
-
Business - The Wall Street Journal
Activist Starboard Value Takes $1 Billion Stake in Pfizer
The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments has slowed.Yesterday -
World - The New York Times
A Young Activist Arrested in Zimbabwe Holds Onto Her ‘Why’
Namatai Kwekweza said she remained committed to her advocacy for change in Africa, despite a harrowing experience in Zimbabwe.4 hours ago -
Business - MarketWatch
The bull market is nearing its second birthday. Here’s why it will likely continue.
The bull market in U.S. stocks is about to turn two years old, the latest milestone for a rally that has surpassed the expectations of all but the most bullish investors on Wall Street.12 hours ago -
Business - MarketWatch
Why Super Micro’s stock is rocketing toward its best day in seven months
Super Micro announced a liquid-cooling offering and said it’s shipping more than 100,000 graphics processing units each quarter.14 hours ago -
Business - Financial Times
Former Pfizer CEO pitches board on Starboard’s shake-up plan
Ian Read has called his successors about the activist’s ideas for turning around the vaccine maker11 hours ago -
World - The New York Times
Athens Democracy Forum: Young Activists on What Drives Them
Six young people from around the world who attended the Athens Democracy Forum spoke about what drives them and the challenges they face.4 hours ago -
Sports - Yahoo Sports
‘Three-peating is hard’: how loss of focus cost the Las Vegas Aces a dynasty
Becky Hammon blamed her team’s foiled three-peat bid on her players ‘being fricking celebrities’. A return the top won’t be easy, even with the world’s best player15 hours ago -
Sports - Yahoo Sports
Derek Carr leaves Saints' matchup with Chiefs with oblique injury, will undergo MRI
Derek Carr was replaced by Jake Haener after getting hurt in the fourth quarter.3 hours ago - NFL
More from The Wall Street Journal
-
Business - The Wall Street Journal
Decision Time for GM in China: Stay, Scale Back or Go
The country’s sharp shift to EVs and stronger local competition have deflated a key profit engine for the U.S. automaker.2 hours ago -
Business - The Wall Street Journal
Cannae, KDSA Buy Majority Stake in The Watkins Company
Cannae, a Las Vegas-based company led by billionaire Bill Foley, includes holdings in the English Premier League team AFC Bournemouth, restaurant chains Ninety Nine Restaurant & Pub and ...8 hours ago -
Business - The Wall Street Journal
Basic Materials Roundup: Market Talk
Read about Sherwin-Williams, Arcadium Lithium and more in the latest Market Talks covering Basic Materials.9 hours ago -
Business - The Wall Street Journal
Health Care Roundup: Market Talk
Find insight on Pfizer, Riverstone, Top Glove Corp. and more in the latest Market Talks covering the Health Care sector.9 hours ago -
Business - The Wall Street Journal
Thyssenkrupp Reviews Plan to Wean Itself Off Fossil Fuels
The company has been trying to turn the fortunes of its steel business around while making operations more sustainable, an effort complicated by rising costs and market conditions.17 hours ago